Other Names CEK5 ligand; CEK5 receptor ligand; CEK5-L; CEL5-L; EFL-3; EFNB1; ELK ligand; ELK-L; EPH-related receptor tyrosine kinase ligand 2; Ephrin-B1 precursor; EPL2; EPLG2; kinase ephrin-B1; LERK-2; LERK2; STRA1; STRA1 protein
All Sites Human: Tyr329/316; Mouse: Tyr318/319; Rat: Tyr328/-
Storage/Stability Store at -20℃/1 year
Form Or Antibody
Form of Antibody Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Immunogen The antiserum was produced against synthesized phosphopeptide derived from human Ephrin B1/B2 around the phosphorylation site of tyrosine 329 (P-V-YP-I-V).
Purification The antibody was affinity-purified fromrabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Specificty Sensitivity
Specificity/Sensitivity Ephrin B1/B2 (Phospho-Tyr329) antibody detects endogenous levels of Ephrin B1/B2 only when phosphorylated at tyrosine 329.
ReferencesBeckmann M.P., EMBO J. 13:3757-3762(1994).
Davis S., Science 266:816-819(1994).
Ross M.T., Nature 434:325-337(2005).
Research AreaAutophagy antibody Cancer Cardiovascular Cell Biology Epigenetics & Nuclear Signaling Developmental Biologys Immunology Drug Discovery Products Metabolism Neuroscience Signal Transduction Stem Cells